Biggest News Aggregation in the World
๐Ÿ“ฐ Urovant Sciences News

Page 3 - Urovant Sciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Urovant Sciences. Real-time updates on events, politics, business and more.

Urovant Sciences GmbH: Urovant Sciences Receives Best in Category Award for Abstract Highlighting Investigational Novel Gene Therapy, URO-902, Presented at 2022 International Continence Society Conference

Interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel), receives International Continence
United States Sumitovant Biopharma Kenneth Peters Maya Frutiger Alana Darden Powell Department Of Urology At Beaumont Hospital

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Urovant Sciences, Inc.: The Impact of Urinary Incontinence Related to Overactive Bladder on Long-Term Care Residents and Facilities in the U.S. Highlighted in New Survey

Survey of 71 Directors of Nursing (DONs) highlights a need for improved awareness, education, and management of urinary incontinence (UI) related to overactive bladder (OAB) in long-term care (LTC)
United States Thomas Jefferson University Sumitovant Biopharma Maya Frutiger Alana Darden Powell Richard Stefanacci

Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland

Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the Europe Economic Area, UK, and Switzerland. Urovant Sciences
United States United Kingdom Pierre Fabre Sumitovant Biopharma Jim Robinson Maya Frutiger

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science